Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × INDUSTRY × Leukemia × Clear all

Status

Completed 182 Terminated 75 Unknown 33 Recruiting 30 Active not recruiting 17 Withdrawn 13 Not yet recruiting 4 Suspended 3 No longer available 2 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 6 Multiple Myeloma 6 Breast Neoplasms 5 Small Cell Lung Carcinoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 HER2-positive Breast Cancer 3 Thyroid Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Leukemia, Myeloid, Acute 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Head and Neck Neoplasms 2 Glioma 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Medullary 2 Carcinoma, Basal Cell 2 Waldenstrom Macroglobulinemia 1 Urogenital Neoplasms 1 Tumors Harboring NTRK Fusion 1 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Syndrome 1

Interventions

immunotoxin HA22 1 HA 22 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡